Published in Immunology on November 01, 2004
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med (1991) 9.94
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med (1991) 8.78
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med (1996) 6.13
A new member of the immunoglobulin superfamily--CTLA-4. Nature (1987) 5.10
SDS microslab linear gradient polyacrylamide gel electrophoresis. Anal Biochem (1978) 5.04
Induction of tolerance by IL-10-treated dendritic cells. J Immunol (1997) 4.65
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A (1996) 4.64
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med (1997) 2.51
Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol (1988) 2.45
A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol (1994) 1.97
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood (1998) 1.22
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med (1994) 1.20
Sensitivity and reproducibility in adenoviral infectious titer determination. Nat Med (1997) 1.17
Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta. Transplantation (1998) 0.97
Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens (1999) 0.95
Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice. Gene Ther (2001) 0.93
Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation (2002) 0.86
A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation (2000) 0.85
The migration of Langerhans' cells into and out of lymph nodes draining normal, carcinogen and antigen-treated sheep skin. Immunol Cell Biol (1994) 0.83
Generation and characterization of ovine dendritic cells derived from peripheral blood monocytes. Immunology (2002) 0.81
Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther (2001) 0.80
Abrogation of afferent lymph dendritic cell function after cutaneously applied chemical carcinogens. Cell Immunol (1995) 0.79
Combined anti-vascular cell adhesion molecule-1 and anti-leukocyte function-associated molecule-1 monoclonal antibody therapy does not prolong allograft survival in an ovine model of renal transplantation. Transplantation (1998) 0.79
Additive efficacy of CTLA4Ig and OX40Ig secreted by genetically modified grafts. Transplantation (2000) 0.77
Cloning and expression of the ovine CD40 molecule and the inhibition of the mixed lymphocyte reaction by the ovine CD40(e)-EGFP fusion protein. Vet Immunol Immunopathol (2002) 0.77
Cloning and sequence comparison of sheep CD28 and CTLA-4. Immunogenetics (1999) 0.77
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol (2006) 1.73
Effect of interleukin-2 receptor antibody therapy on acute rejection risk and severity, long-term renal function, infection and malignancy-related mortality in renal transplant recipients. Transpl Int (2010) 1.39
Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks. Transpl Int (2011) 1.38
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood (2006) 1.26
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int (2005) 0.97
Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation (2006) 0.86
Site-specific protein modification to identify the MutL interface of MutH. Nucleic Acids Res (2003) 0.84
Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal vs. long-term cyclosporin therapy in Australia. Clin Transplant (2006) 0.83
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. Transpl Int (2007) 0.82
Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. Immunol Lett (2008) 0.82
Non-human primate dendritic cells. J Leukoc Biol (2011) 0.82
A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients. Transpl Int (2014) 0.80
A review of utility-based allocation strategies to maximize graft years of deceased donor kidneys. Nephrology (Carlton) (2011) 0.80
MHC Class II DRB genotyping is highly predictive of in-vitro alloreactivity in the common marmoset. J Immunol Methods (2006) 0.80
IFN-gamma generates maturation-arrested dendritic cells that induce T cell hyporesponsiveness independent of Foxp3+ T-regulatory cell generation. Immunol Lett (2010) 0.80
Monoclonal antibodies generated by DNA immunization recognize CD2 from a broad range of primates. Immunol Cell Biol (2009) 0.79
Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis. Angiogenesis (2007) 0.78
Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients. Nephrology (Carlton) (2013) 0.78
Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium. J Immunol (2005) 0.78
Prospective observational study of sirolimus as primary immunosuppression after renal transplantation. Transplantation (2009) 0.78
Extrafacial microcystic adnexal carcinoma: case report and review of the literature. Dermatol Surg (2009) 0.78
Cloning and expression of the ovine CD40 molecule and the inhibition of the mixed lymphocyte reaction by the ovine CD40(e)-EGFP fusion protein. Vet Immunol Immunopathol (2002) 0.77
Disseminated microsporidiosis with Encephalitozoon species in a renal transplant recipient. Nephrology (Carlton) (2012) 0.77
Geographic variance in access to renal transplantation in Australia. Transplantation (2003) 0.76
Insulin-Like growth factor-II (IGF-II) prevents proinflammatory cytokine-induced apoptosis and significantly improves islet survival after transplantation. Transplantation (2013) 0.76
Spontaneous glomerular mesangial lesions in common marmoset monkeys (Callithrix jacchus): a benign non-progressive glomerulopathy. J Med Primatol (2014) 0.76
Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction. Immunology (2006) 0.76
A prospective, multinational pharmacoepidemiological study of clinical conversion to sirolimus immunosuppression after renal transplantation. J Transplant (2012) 0.75
Propagation and characterisation of dendritic cells from G-CSF mobilised peripheral blood monocytes and stem cells in common marmoset monkeys. J Immunol Methods (2009) 0.75
A Single Center Experience With Adult Dual Kidney Transplant. Exp Clin Transplant (2015) 0.75